Services

Respiratory Strategy, Delivered as Business Decisions.

Engagements are scoped around the decision you are facing—portfolio, device, manufacturing, institutional access or full launch.

Services

Where I Help Respiratory Businesses Win

01

Respiratory Portfolio Strategy

Identify the right products, molecules, combinations and dosage forms for your business model.

02

Inhalation Device Strategy

Evaluate DPI, MDI and nebulization opportunities, device platforms and manufacturing considerations.

03

Third-Party Manufacturing Strategy

Develop a structured framework for evaluating respiratory manufacturers, capabilities, quality systems and commercial economics.

04

Institutional Sales Strategy

Build hospital, procurement, tender, KOL and key-account strategies for respiratory portfolios.

05

Brand & Commercial Strategy

Create differentiated positioning, pricing architecture and go-to-market plans.

06

Respiratory Business Launch

Build the complete roadmap from opportunity assessment to commercial launch.

Institutional Business

From Pulmonologist to Procurement.

Pulmonologist
HOD / Clinical Team
Pharmacy
Purchase
Finance
Procurement
Supply & Reorder

Clinical adoption and commercial access must be designed together.

Hospital Segmentation
Key Account Strategy
KOL Mapping
Formulary Strategy
Tender Strategy
Institutional Pricing
Sales Team Deployment
Account Growth

Strategic Engagement Model

How an Engagement Actually Runs

Challenge

Entrepreneur wants to enter respiratory with limited capital.

Approach

  1. Market mapping
  2. Portfolio scoring
  3. Device evaluation
  4. Manufacturer screening
  5. Institutional strategy

Output

Prioritized portfolio + manufacturing strategy + commercial roadmap.

Illustrative consulting scenario.

Consultation

Start With a Respiratory Portfolio Audit

A focused diagnostic session for entrepreneurs and pharma business owners who want to evaluate a respiratory opportunity before committing significant capital.

  • Market opportunity review
  • Current portfolio review
  • Investment-range discussion
  • Product strategy
  • Device strategy
  • Manufacturing considerations
  • Institutional potential
  • Priority action plan